JSPR · Jasper Therapeutics, Inc.
$0.62
+0.02 (+3.75%)
At close · Jul 30
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$16.80M
Shares
28.00M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-01 | 8,036 | $0.42 | $3,375 |
| 2026-06-30 | 3,462 | $0.42 | $1,454 |
| 2026-06-29 | 80,013 | $0.34 | $27,204 |
| 2026-06-16 | 335 | $0.48 | $161 |
| 2026-06-15 | 683 | $0.46 | $314 |
| 2026-06-10 | 11,440 | $0.47 | $5,377 |
| 2026-05-27 | 757 | $0.91 | $689 |
| 2026-05-11 | 1 | $0.93 | $1 |
| 2026-05-06 | 60 | $0.97 | $58 |
| 2026-05-04 | 939 | $0.93 | $873 |
Showing 1–10 of 10 settlements